A
MIRM icon

AlphaQuest’s Mirum Pharmaceuticals MIRM Stock Holding History

AlphaQuest’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,551
Closed -$517K – 1232
2025
Q4 		$517K Sell
6,551
-6,034
-48% -$433K 0.03% 797
2025
Q3 		$923K Buy
12,585
+2,802
+29% +$178K 0.06% 465
2025
Q2 		$498K Sell
9,783
-12,797
-57% -$570K 0.05% 597
2025
Q1 		$1.02M Buy
22,580
+20,751
+1,135% +$978K 0.11% 289
2024
Q4 		$75.6K Buy
1,829
+1,658
+970% +$69.1K 0.01% 1183
2024
Q3 		$6.67K Sell
171
-971
-85% -$38.7K ﹤0.01% 1571
2024
Q2 		$39K Buy
1,142
+1,127
+7,513% +$29.5K 0.01% 1150
2024
Q1 		$377 Sell
15
-6,548
-100% -$180K ﹤0.01% 1562
2023
Q4 		$194K Buy
+6,563
New +$199K 0.04% 627

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

AlphaQuest's MIRM Position: Q1 2026 in Review

AlphaQuest sold out of Mirum Pharmaceuticals (MIRM) in Q1 2026, closing a stake of 6,551 shares — an estimated $517K sold.

AlphaQuest first reported a position in MIRM in Q4 2023 and held it in 9 quarters. The position peaked at $1.02M in Q1 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • AlphaQuest reported no remaining Mirum Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 6,551 Mirum Pharmaceuticals shares in Q1 2026, an estimated $517K.
  • AlphaQuest first reported a position in Mirum Pharmaceuticals in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Mirum Pharmaceuticals position peaked at $1.02M in Q1 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.